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Available online 7 May 2011Abstract Neural progenitor cells (NPCs) are promising candidates for cell-based therapy of neurodegenerative diseases;
however, safety concernsmust be addressed through transplantation studies in large animalmodels, such as the pig. The aim of this
study was to derive NPCs from porcine blastocysts and evaluate their in-vitro differentiation potential. Epiblasts were manually
isolated from expanded hatched blastocysts and cultured on MEF feeder cells. Outgrowth colonies were passaged to MS5 cells and
rosetteswere further passaged toMatrigel-coated dishes containing bFGF and EGF. Three NPC lines were establishedwhich showed
expression of SOX2,NESTIN andVIMENTIN.One linewas characterised inmoredetail, retaining a normal karyotypeand proliferating
formore than threemonths in culture. Following differentiation, TUJIwas significantly up-regulated in protocol 2 (RA and SHH; 58%
positive cells) as were NF and TH. In contrast,MBP was significantly up-regulated in protocol 3 (FGF8 and SHH; 63% positive cells),
whereas, GFAPwas significantly up-regulated in protocols 1–4 (33%, 25%, 43% and 22%). The present study provides the first report
of a porcine blastocyst-derived NPC line capable of differentiating into both neurons and glia, which may be of paramount
importance for future transplantation studies in large animal models of neurodegenerative diseases.
© 2011 Elsevier B.V. All rights reserved.Introduction
Neural progenitor cells (NPCs) can be induced to form
neurons, astrocytes and oligodendrocytes by either instruc-
tive paracrine cues, or by selective survival mechanisms
(Mehler and Kessler, 1999). When isolated and cultured
in-vitro, NPCs are capable of long-term culture in the
presence of basic fibroblast growth factor (bFGF) and
epidermal growth factor (EGF) (Andersen et al., 2009). InAbbreviations: AA, Ascorbic acid; BDNF, Brain-derived neurotrophic fa
FGF8, Fibroblast growth factor 8; GDNF, Glial cell line-derived neurotrop
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doi:10.1016/j.scr.2011.04.004the human fetal brain, the majority of NPCs are located in
the cerebral cortical ventricular zone (VZ) and in the
subventricular zone (SVZ) of the lateral ventricular wall. In
the adult brain, they are also present in the subgranular zone
(SGZ) of the hippocampal dentate gyrus (Ma et al., 2009).
Human NPCs are characterized by expression of the
transcription factors SOX2 and PAX6, the intermediate
filament NESTIN, as well as the RNA binding protein MUSASHI
(Ma et al., 2009; Maisel et al., 2007). However, thector; bFGF, Basic fibroblast growth factor; ESC, Embryonic stem cell;
hic factor; ICM, Inner cell mass; iPSC, Induced pluripotent stem cell;
, 1 - methyl 4 - phenyl - 1, 2, 3, 6 - tetrahydropyridine; MS5, Mouse
utgrowth colony; PDGF, Platelet-derived growth factor; RA, Retinoic
one; VZ, Ventricular zone.
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125Porcine epiblast-derived neural progenitor cells form neurons and glia in2vitrotranscriptional profile of fetal and adult NPCs does differ,
indicating a fundamental difference in the way these cells
may maintain their neuroprogenitor state (Maisel et al.,
2007). Human NPCs can also be established from pluripotent
cells in-vitro, such as embryonic stem cells (ESCs), which
represent an attractive alternative to brain-derived NPCs
due to the potential to generate unlimited amounts of cells.
ESC-derived NPCs share many markers with their fetal
counterparts such as expression of SOX1, SOX2, NESTIN and
MUSASHI (Shin et al., 2007).
Research in rodents suggests that NPCs are interesting
candidates for cell-based therapy of various neurodegener-
ative diseases. For example, transplantation of NPCs can
improve cognition in a mouse model of Alzheimer's disease
(Blurton-Jones et al., 2009), induce remyelination in a mouse
model of multiple sclerosis (Pluchino et al., 2003) and
improve locomotion and respiration in a rat model of
Amyotrophic Lateral Sclerosis (Lepore et al., 2008). Several
groups have furthermore shown that transplantation of ESC-
derived dopaminergic neurons can restore motor function in
a rat model of Parkinson's disease (Roy et al., 2006; Geeta
et al., 2008; Yang et al., 2008). Although these studies
represent a large step toward cell based-therapy in humans,
there are considerable differences between rodent and
human brain structure and function, including altered
astrocyte activity (Oberheim et al., 2009) and brain aging
processes (Oh et al., 2009). Furthermore, despite a general
lack of tumor formation during allotransplantation in
rodents, a documented case of a malignant tumor formation
has been reported following transplantation of human NPCs
into the brain of an Ataxia Telangiectasia patient (Amariglio
et al., 2009). The large differences between rodent and
human neurobiology underscore the need for more detailed
non-rodent pre-clinical studies to understand and minimize
the risks of NPC-transplantation.
Within the field of translational neuroscience, the pig is
poised to become a pivotal biomedical model for testing the
safety and potential of allotransplantation. The pig is an
excellent candidate for this role, as it resembles man in size,
anatomy and physiology (Lind et al., 2007); all of which are
important aspects when studying diseases affecting a
complex organ, such as the brain. The minipig is particularly
ideal for studying Parkinson's disease, due to its similar
anatomy within the substantia nigra (Nielsen et al., 2009)
and development of Parkinsonian-like symptoms when
treated with the neurotoxin MPTP (Bjarkam et al., 2008).
In addition, the popularity of somatic cell nuclear transfer in
livestock species facilitates the generation of transgenic pig
models, such as the minipig model of Alzheimer's disease
(Kragh et al., 2009). Establishment of transgenic NPC-lines
from such in-vivo disease models would allow for detailed
studies on disease mechanisms, as well as in-vitro drug
screening.
The establishment of NPCs from pluripotent cells in
ungulates, such as the pig, is currently hampered by the
fact that ICM/epiblast cells cannot be maintained long-term
in these species (Vackova et al., 2007). Hence, only a few
studies have investigated the potential of in-vitro generated
NPCs in large mammals. One study performed in a bovine
system showed that neural crest progenitor cells could be
derived directly from the inner cell mass (ICM) of in-vitro
produced blastocysts (Lazzari et al., 2006). These cells couldbe maintained in-vitro for more than 112 days and when
growth factors were withdrawn they differentiated into
mature neural and glial subtypes, as well as chondrocytes
and smooth muscle cells. In addition, Puy and co-workers
have shown that rosettes generated from porcine ICM cells
can give rise to NPCs, which could be maintained for up to
2 months in-vitro. However, the differentiation potential of
these cells was limited to glial cells such as astrocytes and
oligodendrocytes (Puy et al., 2010). Recent reports on the
generation of porcine induced pluripotent stem cells (iPSCs)
are opening new exciting possibilities for the derivation of
NPCs in the future (Esteban et al., 2009; Ezashi et al., 2009;
Wu et al., 2009).
To promote the development of the pig as a large animal
model of NPC transplantation, a stable, porcine embryo-
derived NPC line with the capacity to differentiate into both
neural- and glial cells is required. The aim of the present study
was: 1) to isolate and characterize NPCs from porcine epiblast
cells and, 2) to evaluate whether the NPCs can be cultured
long-term and differentiate into neural- and glial cells.
Results
Derivation of NPC lines from porcine epiblast cells
A timeline showing the derivation anddifferentiation ofNPCs is
presented in Fig. 1A. A total of 66 epiblasts were isolated from
Day 9 expanded hatched blastocysts (Fig. 1B, C), classified
according to Vejlsted and colleagues as early pre-streak I stage
embryos containing a clear oval-shaped epiblast (Vejlsted et
al., 2006) and cultured onmouse embryonic feeder (MEF) cells.
On Day 4, 34 outgrowth colonies (OCs) had formed (52%). Some
of the OCs grew as a central dense core, resembling the
embryonic epiblast, surrounded by a monolayer of presump-
tive hypoblast cells, whereas, others grew in a monolayer of
ESC-like cells (Fig. 1D, suppl. Fig. 1A, J). Both types of OCs
presented typical ESC-like morphology with a large nuclear–
cytoplasmic ratio containing one or two prominent nucleoli
and showed nuclear-specific staining of OCT4. To promote
neural differentiation, OCs were co-cultured with mouse MS5
stromal cells, which have previously been reported to improve
neural differentiation of human ESC due to secretion of
neurogenic factors (Barberi et al., 2003). Around Day 12–17,
round or elongated rosettes with a central lumen started to
form in the OCs (Fig. 1E, suppl. Fig. 1B, K).When rosetteswere
isolated and cultured in Matrigel-coated dishes in N2 medium
containing bFGFandEGF, a population of cells rapidly grew out
(Fig. 1F, suppl. Fig. 1C, L), which presented a bipolar
morphology with large nuclei containing two or more
prominent nucleoli (Fig. 1G). After the first passage, the
cells attained a uniformmorphology and neurospheres formed
spontaneously during the first three passages or when cultured
in non-coated dishes (Fig. 1H). When bFGF and EGF were
withdrawn from the medium, the cells obtained a neuronal-
like morphology with protrusions extending from individual
soma (Fig. 1I).
Proliferation and karyotyping of NPCs
Three individual NPC lines were established, of which one
was subjected to detailed characterization. Cell doublings
Figure 1 Derivation and morphology of neural progenitor cells. (A) Timeline showing the sequential steps for derivation of neural
progenitor cells (NPCs) from porcine epiblast cells and the five different protocols used for generation of neural- and glial cells.
(B) Expanded hatched blastocyst on Day 9. (C) Isolation of epiblast from the surrounding trophectoderm. Arrowhead points to an
isolated epiblast. (D) Epiblast monolayer outgrowth colony grown for 5 days on mouse embryonic feeder (MEF) cells. (E) Neural rosette
formed from epiblast cells after 17 days culture on MEF and MS5 feeder cells. Arrow points to a rosette structure. (F) Neural rosette
isolated and cultured in Matrigel-coated dishes in NPCmedium containing bFGF and EGF. Arrow points to outgrowing NPCs. (G) Closeup
of NPCs derived from neural rosettes. (H) Neurosphere spontaneously formed during passage 3. (I) Neuronal-like morphology of NPCs
cultured in medium without bFGF and EGF. Scale bars represent 0.1 mm.
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passage from 1 to 15. Initially, the proliferation rate of the
NPCs was exceptionally high with around 10 doublings each
passage, however, at later passages this decreased to around
2.5 doublings for each passage, which remained relatively
stable (Fig. 2A). The proliferation marker KI67, which was
examined by immunocytochemistry, was expressed in 55.8%
of the NPCs at passage 3 (Fig. 2B−D). Cytogenetic analysis of
NPCs at passage 7 revealed a normal 38, XX karyotype with
all analyzed metaphases free of any discernable cytogenetic
abnormalities (Fig. 2E). The cells have been maintained for
more than three months (30 passages) without losing their
proliferative potential.Comparative real-time PCR analysis of NPCs
Todetermine thenature of theNPCs, the cellswereanalyzedat
passage 5, 21 and 30 by comparative real-time PCR. Reactions
were performed with porcine specific primers of NPCs and
mature neurons and glia, based on previous characterization of
human NPCs. All reactions yielded a single transcript and
amplicons were confirmed by sequencing. Reference genestested on all the samples detected consistent levels of
transcripts, indicating integrity of the cDNA samples (Suppl.
Fig. 4). GAPDH, which was determined to be the most optimal
reference gene, was subsequently used for normalization.
Expression of the transcription factor SOX2 was three fold
higher at passage 5 compared to fetal brain (control tissue)
(Fig. 3A). At passage 21, this level was around 1.5 and at
passage 30 it was around 1, indicating some down-regulation,
despite maintaining a relatively high expression. The
intermediate filament NESTIN was four and five folds higher
than the control tissue at passage 5 and 21, respectively, but
showed a decrease to around 2 fold at passage 30 (Fig. 3B). In
contrast, the intermediate filament VIMENTIN was more
stable, showing 8 to 13 folds higher expression of transcripts
than the control tissue at all the examined stages (Fig. 3C).
BETA-TUBULIN III (TUJI), considered a marker of immature
neurons, was almost undetectable at all passages (Fig. 3D).Immunocytochemical analysis of NPCs
Immunocytochemical analysis with an antibody against OCT4
(considered a marker of pluripotency in human and mice),
Figure 2 Proliferation and karyotyping of neural progenitor cells. (A) Total cell doublings of neural progenitor cells (NPCs),
estimated by cell countings at each passage (3–4 days interval). (B) KI67 staining of NPCs at passage 3. (C) Hoechst staining of NPCs at
passage 3. (D) Merge of B and C. Scale bars represent 0.05 mm. (E) A representative 38, XX karyotype prepared from passage 7 NPCs
using standard cytogenetic techniques and Giemsa staining.
Figure 3 Comparative real-time PCR expression in neural progenitor cells (NPCs). Expression of NPC-markers in porcine NPCs at
passage 5, 21 and 30. (A) SOX2 expression. (B) NESTIN expression. (C) VIMENTIN expression. (D) TUJI expression. The expression was
measured by comparative real-time PCR with Day 42 porcine brains as reference tissue. The experiments were performed in biological
triplicates and normalized to the housekeeping gene GAPDH. Error bars represent the standard deviation of the mean.
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Figure 4 Immunocytochemistry of neural progenitor cells (NPCs). Staining of NPCs with NPC-markers at passage 3. (A) SOX2.
(D) NESTIN. (G) VIMENTIN. (J) PAX6. (M) TUJI. (B, E, H, K, and N) Hoechst. (C, F, I, L and O) Merge of primary antibody staining and
Hoechst. Scale bars represent 0.05 mm.
128 M.A. Rasmussen et al.showed nuclear localized OCT4 labeling in OCs, whereas this
marker was completely absent in the NPCs at passage 4 (data
not shown). In contrast, quantitative immunocytochemical
analyses showed nuclear localization of SOX2 in 99.3% of the
NPCs at passage 4 (Fig. 4A–C). The NPCs also showed
cytoplasmic localization of NESTIN (Fig. 4D–F) and VIMENTIN
(Fig. 4G–I) in 96.0% and 99.6% of the examined cells,
respectively. Furthermore, nuclear localization of PAX6 was
observed in 99.1% of the cells (Fig. 4J–L). In contrast, TUJI
(Fig. 4M–O) was localized to the cytoplasm in only 0.3% of
the cells, and NCAM staining was negative (data not shown).To further analyze the NPCs, staining's with GFAP and SSEA1
(considered markers of human radial glial cells) were carried
out, however, in both cases thesemarkerswere negative (data
not shown). The observed expression profile was confirmed for
two additional NPC lines at comparable passages using
immunocytochemistry (Suppl. Fig. 1D–I, M–R). Immunocyto-
chemistry performed at passage 16 confirmed nuclear
localization of SOX2 and cytoplasmic staining of NESTIN and
VIMENTIN, whereas, PAX6 was low at this stage and a weak
cytoplasmic TUJI staining was observed in a slightly higher
percentage of the cells (Suppl. Fig. 2). Therefore, it would
129Porcine epiblast-derived neural progenitor cells form neurons and glia in2vitroseem that the cellular phenotype could be changing somewhat
over extended culture periods.
Immunohistochemical analysis of Day 42 fetal brain
Immunohistochemical analysis of a Day 42 porcine fetal brain
identified specific areas that showed localization of NPC-
markers including the developing nasal conchae, the neural
layer of the retina, and the ventricular zone (VZ) of the lateral
ventricle (Fig. 5A). In the VZ, nuclear localization of KI67,
SOX2, and PAX6 and cytoplasmic localization of NESTIN and
VIMENTIN was observed (Fig. 5B–F), whereas, the surrounding
marginal zone (MZ) displayed cytoplasmic localization of TUJI
and NCAM (Fig. 5G–H), and GFAP was negative (data not
shown). Localization of KI67, SOX2, PAX6, NESTIN, and TUJI
was also observed in the developing nasal conchae and KI67,
SOX2, PAX6, NESTIN, VIMENTIN, TUJI, and NCAM in the neural
layer of the retina (data not shown).
Morphology of differentiated NPCs
To test the differentiation potential of the NPCs, five different
protocols used for differentiation of human and mouse NPCs
were applied. All the protocols comprised removal of bFGF and
EGF from the culture media at passage 3 and addition of
specific growth factors to promote the generation of different
populations of neural- and glial cells. In protocol 1 (without
growth factors for spontaneous differentiation of NPCs
(Joannides et al., 2007)) the cells mainly attained amultipolar
morphology with several protrutions extending from a single
soma (Suppl. Fig. 3B). In protocol 2 (including RA, SHH, BDNF
and AA for generation of motoneurons (Lee et al., 2007))
extensive clustering of cells with a bipolar morphology was
apparent with large cytoplasmic protrutions extending from
clusters of soma (Suppl. Fig. 3C). In protocol 3 (containing
FGF8, SHH, BDNF and AA for generation of dopaminergic
neurons (Perrier et al., 2004)) clustering of cells with a
multipolar morphology was mainly observed and the culture
was passaged on Day 9 due to continued proliferation (Suppl.
Fig. 3D). In protocol 4 (containing PDGF for generation ofFigure 5 Immunohistochemistry of porcine fetal brain. Immunoh
(A) Morphology of the telencephalon, Scale bar represent 1 mm. Inset s
ventricular zone (VZ) and themarginal zone (MZ), respectively. Scale b
the lateral ventricle. (B) KI67. (C) SOX2. (D) NESTIN. (E) VIMENTIN. (Foligodendrocytes (Hu et al., 2008)) cells with larger nuclei
were mostly observed, often with wide, cytoplasmic pro-
trusions (Suppl. Fig. 3E). Again, continued growth required the
cells to be passaged on Day 9. Finally, in protocol 5 (containing
RA and LIF for generation of astrocytes (Asano et al., 2009))
clustering of cells with a multipolar morphology was most
predominant (Suppl. Fig. 3F).
Comparative real-time PCR analysis of
differentiated NPCs
Comparative real-time PCR was performed at the end point of
the differentiation experiment. NESTIN expression had de-
creased to around half the level of undifferentiated NPCs in
Protocols 1 and4,whereas, in the remaining protocols the levels
were unaltered (Fig. 6A). The expression of the early neuronal
marker TUJI was 10 and 5 fold higher than in undifferentiated
NPCs in protocols 2 and 5, respectively, whereas this marker
only showed a slight up-regulation in protocols 1, 3 and 4
(Fig. 6B). Only protocol 2 showed a significant difference from
undifferentiated NPCs. The same expression profile was
identified for markers of more mature neurons such as
NEUROFILAMENT (NF) and TYROSINE HYDROXYLASE (TH),
which were both significantly up-regulated in protocol 2
(Fig. 6C–D). GFAP, a marker of astrocytes, was around 100
fold higher in protocol 1, 2, 3 and 4, which was significantly
different from undifferentiated NPCs (Fig. 6E). In contrast,
GFAPwas not statistically different from undifferentiated NPCs
in protocol 5. Finally, a marker of oligodendrocytes, MYELIN
BASIC PROTEIN (MBP), was tested; however, this marker was
around the detection limit in fetal brain. Nevertheless, it was
significantly up-regulated around 12 fold compared to undiffer-
entiated NPCs in protocol 3, whereas, in the other protocols,
MBP was only up-regulated between 1 and 5 fold (Fig. 6F).
Immunocytochemical analysis of differentiated cells
Immunocytochemical analysis and quantification of differ-
entiated cells showed that cytoplasmic localization of
NESTIN was still observed in 59%, 68%, 52%, 12% and 80% ofistochemical staining of a porcine brain from a Day 42 fetus.
hows a close up of the lateral ventricle with arrows pointing to the
ars represent 0.5 mm. (B–H) Antibody stainings of the VZ andMZ of
) PAX6. (G) TUJI. (H) NCAM. Scale bars represent 0.1 mm.
Figure 6 Comparative real-time PCR expression in differentiated cells. Expression of neural- and glial cell markers in neural
progenitor cells (NPCs) submitted to five differentiation protocols (protocol 1–5). (A) NESTIN. (B) TUJI. (C) NF. (D) TH. (E) GFAP and
(F) MBP. The expression was measured by comparative real-time PCR relative to the expression in undifferentiated NPCs. Samples
were normalized to the housekeeping gene GAPDH. The experiments were performed in biological triplicates by differentiating the
NPCs at passage 3. Significant difference from undifferentiated NPCs is indicated with different significance levels by ***=pb0.001,
**=pb0.01 and *=pb0.05. Error bars represent the standard deviation of the mean.
130 M.A. Rasmussen et al.the cells in protocols 1, 2, 3, 4 and 5, respectively, indicating
that complete down-regulation of this marker did not occur
(Fig. 7A–C). Cytoplasmic localization of TUJI was found in
34%, 58%, 29%, 21% and 80% of the cells in protocols 1–5,
respectively (Fig. 7D–F), which corresponded relatively well
with the observed expression profile of TUJI. In addition,
cytoplasmic localization of TH was observed in protocol 2,
but only in few cells (Fig. 7G–I). Cytoplasmic localization of
GFAP was observed in 34%, 25%, 43%, 22% and 13% of the cells
in protocols 1–5, respectively (Fig. 7J–L), which also
corresponded more or less with the expression profile of
this marker. Finally, cytoplasmic localization of O4, a marker
of type I and II pro-oligodendrocytes but not of O-2A
progenitor cells (Dhara et al., 2008), was observed in
protocols 3 and 4 at 30% and 63% of the cells, respectively
(Fig. 7M–O).Discussion
The current study presents for the first time a porcine
blastocyst-derived NPC line with the ability to differentiate
into both neural- and glial cells. Co-culture of porcine
epiblast cells with MS5 cells gave rise to formation of rosettes
after 12–17 days in culture, which is comparable to ESCs
cultured under the same conditions (Barberi et al., 2003;
Perrier et al., 2004). The rosette-derived NPCs were cultured
in the presence of bFGF, a well-known mitogen of neuralspecification, and EGF, which is reported to promote self-
renewal of NPCs (O'Keeffe et al., 2009) and have currently
been cultured for more than three months without losing
their proliferative capacity.
An important feature of stem cells is their ability to grow
indefinitely in culture; hence, to shed light on this issue, cell
doublings were monitored over time. The NPCs were capable
of more than 60 population doublings without ceasing to
proliferate, although an initially high proliferation rate
followed by a period of slower, yet stable proliferation was
observed. This kind of growth is best described as logarithmic
growth, which has previously been reported for human NPCs
(Reubinoff et al., 2001). However, with the symmetrical
divisions of undifferentiated NPCs, one would ideally expect
an exponential growth, which has been reported in other
studies (Lazzari et al., 2006; Hong et al., 2008).
KI67 staining at passage 3 showed that 55.8% of the NPCs
expressed this proliferation marker, which is comparable to
the 50% KI67 positive cells found by Puy et al. (2010). In
comparison, human NPCs have been shown to express KI67 in
53.5% of the cells, whereas, mouse NPCs express KI67 in 80%
of the cells (Sun et al., 2009), indicating that the NPCs have
similar proliferation rate as human NPCs. The observation
that the NPCs were karyotypically normal at passage 7
indicated that the culture conditions did not give rise to
cytogenetic abnormalities at this stage of development.
The NPCs were positive for SOX2, NESTIN and VIMENTIN as
detected by comparative real-time PCR and verified by
Figure 7 Immunocytochemistry of differentiated cells. Antibody stainings with neural- and glial markers. Differentiation protocols
are shown in bracket. (A) NESTIN (protocol 5), (D) TUJI (protocol 5). (G) TH (protocol 2). (J) GFAP (protocol 3). (M) O4 (protocol 4).
(B, E, H, K, and N) Hoechst. (C, F, I, L and O) Merge of primary antibody staining and Hoechst. Scale bars represent 0.05 mm.
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most of the cells corroborates their NPC identity and points to
a nearly homogeneous population. Furthermore, pluripotent
cells did not seem to be present among the NPCs as staining for
the pluripotency marker OCT4 was negative. To test the
reproducibility of the method, two additional NPC lines were
established and analyzed by immunocytochemistry, which
showed a similar expression profile. Puy and colleagues found
that porcine ICM-derived NPCs were positive for SOX2, NESTIN
and VIMENTIN (Puy et al., 2010), which match our present
findings very well. Nevertheless, the cellular phenotype of theNPCs did seem to change over a prolonged period of culture, as
TUJI was observed in a higher number of cells at passage 15,
whereas, PAX6 was not observed anymore. This could be
attributed to in vitro maturation of the NPCs, which
corresponds to what is observed in vivo, since embryonic and
adult brain-derived NPCs show different expression profiles.
Analysis of Day 42 porcine fetal brain using immunohis-
tochemistry showed expression of KI67, SOX2, NESTIN,
VIMENTIN, and PAX6 in the VZ of the lateral ventricle,
whereas, TUJI and NCAM were predominantly located in the
MZ. Hence, the expression profile of the NPCs derived in this
132 M.A. Rasmussen et al.study corresponds well with fetal NPCs located in the VZ.
When Schwartz and colleagues analyzed porcine fetal-
derived NPCs they also found expression of SOX2, VIMENTIN
and NCAM, whereas NESTIN was not detected due to a lack of
antibody specificity (Schwartz et al., 2005).
GFAP is a marker found in several different cell types. It is
expressed in adult, but not in fetal-derived NPCs (Imura
et al., 2003) and in concert with SSEA1, it is used to
characterize radial glia in the brain (Mo et al., 2007; Howard
et al., 2008). However, GFAP is also considered a marker of
type 2 astrocytes (Talbot et al., 2002). Immunocytochemical
analyses showed that the porcine NPCs were negative for
both GFAP and SSEA1, indicating that they share more
characteristics with fetal-derived NPCs from the VZ. In
contrast, Puy and colleagues found GFAP staining in 13% of
the porcine ICM-derived NPCs (Puy et al., 2010) and it is
possible that these cells had already differentiated into the
astrocyte lineage.
For cells to be characterized as multipotent NPCs, they
must possess the ability to differentiate into both neural- and
glial cells. To determine the differentiation potential of the
NPCs, various combinations of growth factors known to
promote differentiation of human NPCs into mature neurons
and glia were tested. Generation of neurons from NPCs was
most efficient in protocol 2, containing RA, SHH, BDNF and
AA. This was not surprising since RA and SHH are known to
play key roles in neural patterning in the early embryo
(Patten and Placzek, 2000; Maden, 2007). Interestingly, TH,
a marker of dopaminergic neurons, was also detected in
protocol 2, whereas in protocol 3 (containing FGF8 and SHH
for generation of dopaminergic neurons (Perrier et al.,
2004)) TH positive cells were not observed. This could be due
to species-specific differences in response to growth factors,
however, it is more likely due to timing, as sequential
application of FGF8 and SHH has been shown to promote
formation of doperminergic midbrain neurons from human
NPCs (Yan et al., 2005; Hong et al., 2008).
Oligodendrocyte progenitor cells were most abundant in
protocol 4, containing PDGF, as detected by immunocyto-
chemistry with O4. In contrast, expression of the oligoden-
drocyte marker MBP was significantly up-regulated in
protocol 3, as detected by comparative real-time PCR. It is
possible that an extended differentiation period as well as
other factors such as BDNF, GDNF and AA is required for the
final maturation to mature MBP-expressing oligodendro-
cytes. In the human, several authors have previously
reported low quantities of oligodendrocytes from human
ESC-derived NPCs (Reubinoff et al., 2001; Dhara et al.,
2008). However, a protocol for generation of high amounts of
oligodendrocyte progenitor cells from human ESCs has
recently been published, which includes 10 days supplemen-
tation with RA and SHH followed by 20 days supplementation
with bFGF and 2 months maturation in PDGF, Insulin-like
growth factor 1 and Neurotrophin 3. This protocol could be
interesting to apply to the porcine NPCs (Hu et al., 2009).
Astrocytes were generated in protocols 1 to 4, which is in
agreement with the general dogma of spontaneous astrocyte
formation (Trounson, 2006). Surprisingly, the combination of
RA and LIF in protocol 5, which has been shown to yield high
numbers of astrocytes from mouse NPCs (Asano et al., 2009),
had the opposite effect in this study. In human, LIF has been
shown to stimulate long-term culture of undifferentiatedhuman NPCs (Andersen et al., 2009). Hence, it is possible
that LIF was responsible for the inhibitory effect on astrocyte
formation as it was the only factor included exclusively in
protocol 5. For a thorough examination of the long-term
plasticity of the NPCs, differentiation experiments using late
stage NPCs are required; however, this lies beyond the scope
of this study.
Accumulating evidence suggests that NPCs derived from
early-stage cells and embryos possess superior plasticity
compared to those derived from older stages. This is
illustrated in a study by Chung and colleagues, in which
mouse ESC-derived NPCs were able to differentiate into
dopaminergic neurons in culture, whereas, fetal-derived
NPCs from the ventral mesencephalon lacked this ability
(Chung et al., 2006). Furthermore, transplantation of
porcine NPCs derived from Day 22 and Day 27 embryos into
a rat model of Parkinson's disease showed that only the early-
stage cells survived the transplantation (Armstrong et al.,
2003). In another study by Harrower and co-workers, a
significantly improved survival and integration of in-vitro
cultured porcine NPCs compared to primary porcine grafts in
a rat model of Parkinson's disease were observed (Harrower
et al., 2006). Hence, in-vitro culture could play an important
role in resetting the NPCs to an earlier state, perhaps
through erasure of immunological identity. Since the NPCs in
this study are derived directly from the epiblast and cultured
under in-vitro conditions, differentiation, integration and
survival in the porcine brain might be favored compared to
their in-vivo derived counterparts.
Conclusion
The porcine blastocyst-derived NPCs share many character-
istics with human ESC-derived NPCs, such as expression of
NPC markers, their capacity for long-term proliferation and
ability to differentiate into both neurons and glia. As a
result, they may be used in porcine brain transplantation
studies as a model of allogeneic cell replacement therapy.
Pigs are currently considered the standard experimental
model for human brain development, due to their similar
anatomical and physiological characteristics (Lind et al.,
2007) and with the increasing number of porcine disease
models emerging through nuclear transfer (Kragh et al.,
2009) the pig would constitute an outstanding large animal
model to study NPC-based treatment of neurodegenerative
diseases.
Materials and methods
Unless otherwise stated, materials were purchased from
Invitrogen, Carlsbad, CA.
Isolation and culture of epiblast cells
Uteri from four Danish sows (Landrace x Yorkshire crosses)
were artificially inseminated over 2 days with semen from
Duroc boars and collected at a local abattoir 9 days post
insemination (Day 9). Each uterine horn was flushed with
150 ml embryo transfer solution (LIFE Pharmacy, KU,
Frederiksberg, Denmark) containing 0.1% FBS and collected
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DMEM containing HEPES (Sigma-Aldrich, St. Louis, MO) and 10%
FCS by stereo-microscopy. Epiblasts were mechanically isolat-
ed from the surrounding trophectodermand hypoblast of Day 9
expanded hatched blastocysts using insulin needles. The
isolated epiblasts were cultured as outgrowth colonies (OCs)
in dishes containing 2×104/cm2 irradiation inactivated mouse
embryonic fibroblast (MEF) feeder cells (DSMZ, Braunschweig,
Germany) in ESCmedium consisting of knockout DMEM (Sigma-
Aldrich), 10% knockout serum replacement (KSR), 5% FCS, 1%
penicillin/streptomycin (Sigma-Aldrich), 1% non-essential
amino acids (Sigma-Aldrich), 0.2% beta-mercaptoethanol
(Sigma-Aldrich), 20 ng/ml human bFGF and 20 ng/ml human
Activin A (R&D systems,Minneapolis,MN) and cultured at 38 °C
in 20% O2, 5% CO2 in N2.
Derivation of porcine NPCs
MS5 stromal cells (MS5; DSMZ) were cultured for one day in
gelatin-coated dishes in a medium consisting of alpha-MEM
medium (Sigma-Aldrich) containing 10% FBS. On Day 5,
following epiblast isolation, ESC-like areas of OCs were cut
into 4–12 small pieces by use of insulin needles and co-cultured
with 2×104/cm2 MS5 cells in serum replacement medium
containing DMEM, 15% KSR and 2 mM L-glutamine (Perrier
et al., 2004). The cellswere cultured at 38 °C in 20%O2, 5% CO2
in N2 and medium was replaced every 2–3 days without
passage. Rosettes, which typically appeared after 12–17 days
co-culture, were isolated by insulin needles, cut into small
pieces and transferred to Matrigel-coated dishes (BD Bio-
sciences, Franklin Lakes, NJ) inmediumcontaining DMEM/F12,
1xB-27 supplement, 1xN2 supplement, 20 ng/ml EGF (Prospec,
Rehovot, Israel) and 20 ng/ml bFGF and cultured at 38 °C in
20%O2, 5%CO2 inN2withmediumchangeevery 2–3 days. After
8 days, the cells were disaggregated in 1% Trypsin/EDTA and
split into new Matrigel-coated dishes (BD Biosciences) at a
ratio of 1:5 (termedpassage 1), with subsequent passage every
3–4 days. Cells from passage 5, 21 and 30 were sampled for
comparative real-time PCR analysis and from passage 4 and 16
for immunocytochemical analysis.
Proliferation and karyotyping of NPCs
For analysis of cell doublings, trypsin treated cells were
counted at each passage using a haemocytometer and total
cell doublings were calculated (starting from passage 1). To
check for cytogenetic abnormalities, karyotyping of NPCs at
passage 7 was performed according to standard cytogenetic
techniques. Briefly, a 100 mm culture dish of 65% confluent
and dividing cells was treated with 0.1 μg/mL of colcemid
(Sigma-Aldrich) for 25 min, trypsinized, resuspended in a
pre-warmed hypotonic solution of 0.075 M KCl (Sigma-
Aldrich) and incubated at 37 °C for 18 min. Cells were then
fixed at room temperature by resuspending in freshly made
3:1 methanol:glacial acetic acid fixative (Sigma-Aldrich) and
incubated for 1 h. Dry, clean slides were wetted with a drop
of fixative and 15 μL of cellular suspension was dropped onto
the surface and allowed to dry in a humid environment.
Slides were aged in a dry oven at 90 °C for 1 h, cooled to
room temperature, stained in 8% (v/v) Giemsa (Sigma-
Aldrich) in Gurr buffer (pH 6.8) for 2–4 min, rinsed 3 timesin H2O and dried. Fourteen images of metaphases were
captured using standard bright field microscopy and checked
for cytogenetic abnormalities.
Differentiation of NPCs into neurons and glia
To evaluate the differentiation potential of the NPCs, five
alternate differentiation protocols were performed. NPCs at
passage 4 were disaggregated into single cells and seeded at
a density of 1×105/cm2 in Matrigel-coated dishes (BD
Biosciences) and dishes containing Matrigel-coated glass
coverslips (ThermoFisher Scientific, Waltham, MA). The
cells were cultured for a total of three weeks in N2 medium
consisting of DMEM/F12 and 1xN2 supplement in the
following conditions: Protocol 1 (mixed neurons and glia);
N2 medium without growth factors (Joannides et al., 2007).
Protocol 2 (motoneurons); two weeks culture in N2 medium
containing 1 μM all-trans-retinoic acid (RA; Sigma-Aldrich),
200 ng/ml recombinantmurine sonic hedgehog (SHH), 20 ng/ml
human recombinant brain-derived neurotrophic factor
(BDNF, Prospec, Rehovot, Israel), 0.2 mM ascorbic acid (AA;
Sigma-Aldrich) followed by one week maturation in 20 ng/ml
human recombinant glial cell line-derived neurotrophic
factor (GDNF, Prospec, Rehovot, Israel), 20 ng/ml BDNF
(Prospec) and 0.2 mM AA (Sigma-Aldrich) (Lee et al., 2007).
Protocol 3 (Dopaminergic midbrain neurons); two weeks
culture in 200 ng/ml SHH, 100 ng/ml human recombinant
fibroblast growth factor 8 (FGF8), 20 ng/ml BDNF (Prospec)
and 0.2 mM AA (Sigma-Aldrich) followed by one week
maturation in 20 ng/ml GDNF (Prospec) and 20 ng/ml BDNF
(Prospec) and 0.2 mM AA (Sigma-Aldrich) (Perrier et al.,
2004). Protocol 4 (Oligodendrocytes); 20 ng/ml human
recombinant platelet-derived growth factor-AB (PDGF;
Sigma-Aldrich) (Hu et al., 2008) and Protocol 5 (Astrocytes);
1 μMRAand 20 ng/ml recombinantmurine leukemia inhibitory
factor (LIF; Chemicon, Hessen, Germany) (Asano et al., 2009).
Differentiation was performed at 38 °C in 5% O2, 5% CO2 in N2,
with half of the media changed every third day. Only cells in
protocols 3 and 4 were passaged 1:2 on Day 9 due to continued
proliferation. At the conclusion of the experiment, three
samples were obtained from each protocol for comparative
real-time PCR and two samples were obtained for
immunocytochemistry.
RNA purification and reverse transcription
Neural progenitor cells anddifferentiatedcellswere trypsinized
into single cells, placed in lysis buffer (Qiagen, Chatsworth, CA),
snap-frozen in liquid nitrogen and stored at −80 °C. As positive
control tissue, porcine brains from three fetuses, isolated from
the uterus of a Danish sow (Landrace x Yorkshire crosses)
42 days post insemination (Day 42) (Vejlsted et al., 2006), were
isolated from the skull and minced using a razorblade. As
negative control tissue, MS5 cells were cultured as described
above. Both were placed into lysis buffer, frozen in liquid
nitrogen and stored at −80 °C. Total RNAwas purified using the
RNeasy mini or micro kit (Qiagen) and the RNA content and
purity were measured on a Nanodrop 1000 spectrophotometer
(ThermoFisher Scientific). Reverse transcriptionwas performed
using the RevertAid First strand cDNA synthesis kit (Fermentas,
Burlington, ON) according to the manufacturer's instructions.
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Comparative real-time PCR
Comparative real-time PCR using the ΔΔCT method was
performed with a Lightcycler SW480 and SYBR Green I Master
mix (Roche, Basal, Switzerland). PCR conditions were:
45 cycles of denaturation at 95 °C for 10 s, annealing at
58 °C for 10 s and elongation at 72 °C for 20 s. Porcine
specific primers designed using alignment of porcine
sequences with human genes or previously published primers
was used (Suppl. Table 1). Three independent biological
samples were analyzed which were each run in triplicate.
H2O and mouse MS5 cDNA served as negative controls and
pooled brain cDNA from Day 42 porcine fetuses served as
endogenous control tissue. Three different reference genes
were tested on all the samples; glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (Kuijk et al., 2007), Tata box
binding protein 1 (TBP1) (Nygard et al., 2007) and phospho-
glycerate kinase 1 (PGK1) (Boda et al., 2009). GeNorm
(Vandesompele et al., 2002) and NormFinder (Andersen
et al., 2004) were subsequently used to determine the most
optimal reference gene.
Statistical analysis
Comparative real-time PCR samples were normalized using
the ΔΔCt method. The ΔCT value was calculated by
normalizing the CT value of the target gene with the CT
value of the housekeeping gene. The ΔΔCT value was
calculated by normalizing the ΔCT value to the reference
tissue. Finally, the fold change in gene expression was
determined by the equation 2−ΔΔCT. In the differentiation
experiment, calculation of standard deviations as well as
statistical analysis was performed on the 2−ΔΔCT value using
one way ANOVA to analyze the difference between treated
and non-treated samples. Significance was determined as
p≤0.05.
Fixation of cells and tissues
Neural progenitor cells and differentiated cells were cultured
on Matrigel-coated (BD Biosciences) glass coverslips (Thermo-
Fisher Scientific), fixed for 20 min in 4% PFA and stored in 1%
PFA at 4 °C. As a positive control, a head from a Day 42 fetus
was dissected and fixed overnight in 4% paraformaldehyde
(PFA), frozen in Tissue-tek (Sakura Finetek, Torrance, CA), cut
into 5 μm sections using a cryostat and stored at −80 °C. As a
negative control tissue, MS5 cells were cultured as described
above on Matrigel coated (BD Biosciences) glass coverslips
(ThermoFisher Scientific), fixed for 20 min in 4% PFA and
stored in 1% PFA at 4 °C.
Immunocytochemistry
Immunocytochemistry was performed as follows: 30 min
permeabilization in 0.1% Triton X-100 (Sigma-Aldrich), 1 h
blocking in PBS containing 5% Donkey serum (Sigma-Aldrich)
and incubation over night at 4 °C with primary antibodies(Suppl. Table 2) in 0.25% BSA (Sigma-Aldrich), 0.1% Triton
X-100 in PBS. The following day, cells were washed 3 times in
PBS, incubated for 1 h with fluorescent-conjugated secondary
antibodies (Alexa Fluor; 1:400) diluted in 0.25%BSA, 0.1%Triton
X-100 in PBS, washed 3 times in PBS, incubated in 0.1 μl/ml
Bisbenzimide Hoechst (Sigma-Aldrich) and mounted in
fluorescence mounting medium (Dako, Glostrup, Denmark).
TheOCswereused to verify specificity of pluripotencymarkers
and the brain of a Day 42 porcine fetus was prepared as
described above and used to verify specificity of neuronal
antibodies. Mouse MS5 cells were included as a negative
control. All specimens were examined using a Leica DMRB
fluorescentmicroscope and Leica Application Suite 2.81 (Leica
Microsystems). For quantification of positive antibody labeling
of undifferentiated and differentiated cells, a minimum of 500
Hoechst-stained cells per treatment per antibody staining
were counted from eight different, equally distributed
locations on a glass coverslip and compared to the number of
cells with positive staining using ImageJ (Collins, 2007). In
total, 15.500 cells were counted.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2011.04.004.Acknowledgments
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